Stay updated on HER2+ Breast Cancer Adjuvant Trial
Sign up to get notified when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.

Latest updates to the HER2+ Breast Cancer Adjuvant Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to study content are indicated.SummaryDifference0.1%

- Check26 days agoChange DetectedSystem revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check55 days agoChange DetectedA minor website update was applied: Revision: v3.4.2 was added, and older notices including a government funding lapse message and Revision: v3.4.1 were removed. This change does not affect the study data, eligibility criteria, outcomes, or trial status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedA site-wide notice about government funding delays and NIH operating status was added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check69 days agoChange DetectedAdded a glossary toggle and a new 'Last Update Submitted that Met QC Criteria' timestamp, and updated the page to show 'Revision: v3.4.0'. The older variant labels for QC criteria, FEAR Act data, and revision information were standardized or removed.SummaryDifference0.2%

- Check76 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No substantive changes to study details, eligibility criteria, or user interactions are evident.SummaryDifference0.1%

Stay in the know with updates to HER2+ Breast Cancer Adjuvant Trial
Enter your email address, and we'll notify you when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.